Other News To Note
Tuesday, June 5, 2012
China Nuokang Bio-Pharmaceutical Inc., of Beijing, said the independent committee of the company's board of directors evaluating the acquisition proposal from Chairman and CEO Baizhong Xue appointed Lazard and Houlihan Lokey as its independent financial advisors. In May, Xue proposed to acquire the outstanding shares not currently owned by Xue or companies under his control.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.